WeVote
Log In

Bill

BW

Bill

SB 1433

SB 1433 - This act authorizes a sales tax exemption for the sale of all diabetic supplies, as defined in the act. JOSH NORBERG

2026 Regular Session Introduced by Barbara Washington

Missouri bill exempts diabetic supplies from sales tax to reduce patient costs for essential glucose monitoring and insulin administration equipment.

Second Read and Referred S Economic and Workforce Development Committee
0
WeVote Research Nonpartisan
Bill Summary · SB 1433

Legislative bill overview

SB 1433 would exempt diabetic supplies from Missouri's state sales tax, reducing the tax burden on individuals managing diabetes. The bill targets essential medical equipment and supplies such as glucose meters, test strips, lancets, and insulin syringes used in diabetes treatment and monitoring.

Why is this important

Diabetes affects approximately 650,000 Missourians, and the cost of supplies represents a significant ongoing expense for patients. Removing sales tax on these items could reduce annual out-of-pocket costs for diabetic individuals, potentially improving medication adherence and health outcomes, particularly for lower-income residents who may skip or ration supplies due to cost.

Potential points of contention

  • Revenue impact: The sales tax exemption reduces state revenue; fiscal projections would determine whether Missouri can absorb this cost or must offset it elsewhere
  • Definitional scope: Clarity needed on which products qualify (e.g., does it include all glucose monitors, or only certain types? Does it cover continuous glucose monitors?), as overly broad definitions increase costs while narrow ones limit benefits
  • Equity concerns: Critics may argue that blanket exemptions benefit all income levels equally rather than targeting assistance to those most in need, or conversely, that exemptions are insufficient compared to direct patient subsidies

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.